Skip to main content
MedApt
  • Log in

Poor Muscle Health Linked to Higher Gestational Diabetes Risk

Submitted by centrix_admin on Sat, 09/20/2025 - 14:28
  • Read more about Poor Muscle Health Linked to Higher Gestational Diabetes Risk

Glycemic Control in Pregnancy Linked to Risk of LGA Infants in T1D

Submitted by centrix_admin on Sat, 09/20/2025 - 14:25
  • Read more about Glycemic Control in Pregnancy Linked to Risk of LGA Infants in T1D

Automated Insulin Delivery Sustains Glycemic Control in 2–6-Year-Olds with T1D

Submitted by centrix_admin on Sat, 09/20/2025 - 14:21
Tags
Others Delivery devices
  • Read more about Automated Insulin Delivery Sustains Glycemic Control in 2–6-Year-Olds with T1D

TR Reduction After T-TEER Linked to Improved Clinical Outcomes

Submitted by centrix_admin on Sat, 09/20/2025 - 14:00
  • Read more about TR Reduction After T-TEER Linked to Improved Clinical Outcomes

‌New Imaging Approach Improves Non-Invasive PCWP Estimation in HFpEF

Submitted by centrix_admin on Sat, 09/20/2025 - 13:56
  • Read more about ‌New Imaging Approach Improves Non-Invasive PCWP Estimation in HFpEF

Tricuspid Valve Intervention Yields Survival Gains in Select Patient Groups

Submitted by centrix_admin on Sat, 09/20/2025 - 13:53
  • Read more about Tricuspid Valve Intervention Yields Survival Gains in Select Patient Groups

SGLT2 Inhibitors Outperform GLP-1RAs in Preserving Kidney Function in T2D

Submitted by centrix_admin on Sat, 09/20/2025 - 11:18
Tags
Diabetic Nephropathy
SGLT-2 Inhibitor
  • Read more about SGLT2 Inhibitors Outperform GLP-1RAs in Preserving Kidney Function in T2D

Fixed-Dose Empagliflozin/Linagliptin Shows Superior HbA1c Reduction with Metformin

Submitted by centrix_admin on Sat, 09/20/2025 - 11:10
Tags
DPP-4 inhibitors
SGLT-2 Inhibitor
  • Read more about Fixed-Dose Empagliflozin/Linagliptin Shows Superior HbA1c Reduction with Metformin

Injection-Free Exenatide Device Shows Strong HbA1c Reductions in Poorly Controlled T2DM

Submitted by centrix_admin on Sat, 09/20/2025 - 11:03
  • Read more about Injection-Free Exenatide Device Shows Strong HbA1c Reductions in Poorly Controlled T2DM

ESC Congress 2025: Sacubitril/Valsartan Reduces Mortality and Hospitalization in HFrEF With Severe CKD

Submitted by centrix_admin on Fri, 09/19/2025 - 13:01
Tags
Heart Failure
  • Read more about ESC Congress 2025: Sacubitril/Valsartan Reduces Mortality and Hospitalization in HFrEF With Severe CKD

Pagination

  • Previous page ‹‹
  • Page 246
  • Next page ››
Subscribe to Medical Student